Combined effect of recombinant human bone morphogenetic protein-2 and low level laser irradiation on bisphosphonate-treated osteoblasts

키워드

참고문헌 (34)

1. Boonyapakorn T, "Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies", Oral Oncol, 44, pp.857~869 (2008)
2. Marx RE, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", J Oral Maxillofac Surg, 61, pp.1115~1117 (2003)
3. 이정근, "Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report", 대한구강악안면외과학회지, 39(1), pp.9~13 (2013), 대한구강악안면외과학회
4. review:bisphosphonates and osteonecrosis of the jaws, "Ann Intern Med", 2006, 753~761
5. Mavrokokki T, "Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia", J Oral Maxillofac Surg, 65, pp.415~423 (2007)
6. Rodan GA, "Bisphosphonates: mechanisms of action", J Clin Invest, 97, pp.2692~2696 (1996)
7. Sahni M, "Bisphosphonates act on rat bone resorption through the mediation of osteoblasts", J Clin Invest, 91, pp.2004~2011 (1993)
8. Murakami H, "A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders", Bone, 17, pp.137~144 (1995)
9. Aubin JE, "Principles of bone biology" (2002), Academic
10. Tay JY, "Identification of RANKL in osteolytic lesions of the facial skeleton", J Dent Res, 83, pp.349~353 (2004)
11. Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93, pp.165~176 (1998)
12. Khadra M, "Effect of laser therapy on attachment, proliferation and differentiation of human osteoblast-like cells cultured on titanium implant material", Biomaterials, 26, pp.3503~3509 (2005)
13. Urist MR, "Bone: formation by autoinduction", Science, 150, pp.893~899 (1965)
14. Chen D, "Bone morphogenetic proteins", Growth Factors, 22, pp.233~241 (2004)
15. 권택균, "Effect of recombinant human bone morphogenetic protein-2 on bisphosphonate-treated osteoblasts", 대한구강악안면외과학회지, 40(6), pp.291~296 (2014), 대한구강악안면외과학회
16. Marx RE, "Clinical concerns of alendronate use", J Oral Maxillofac Surg, 66, pp.1322~ (2008)
17. Rustemeyer J, "Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literature", Clin Oral Investig, 14, pp.59~64 (2009)
18. García-Moreno C, "Effect of alendronate on cultured normal human osteoblasts", Bone, 22, pp.233~239 (1998)
19. Vitté C, "Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption", Endocrinology, 137, pp.2324~2333 (1996)
20. Nishikawa M, "Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures", Bone, 18, pp.9~14 (1996)
21. Marini H, "OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration", J bone Miner Res, 23, pp.715~720 (2008)
22. Choi ST, "Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis", Rheumatology (Oxford), 47, pp.1775~1779 (2008)
23. Ashizawa N, "Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction", J Clin Invest, 98, pp.2218~2227 (1996)
24. Murry CE, "Macrophages express osteopontin during repair of myocardial necrosis", Am J Pathol, 145, pp.1450~1462 (1994)
25. Ikeda T, "Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta", J Clin Invest, 92, pp.2814~2820 (1993)
26. Reinholt FP, "Osteopontin: a possible anchor of osteoclasts to bone", Proc Natl Acad Sci U S A, 87, pp.4473~4475 (1990)
27. Itoh K, "Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factorkappaB ligand", Endocrinology, 142, pp.3656~3662 (2001)
28. Zheng Y, "BMP2", 7 heterodimer can modulate all cellular events of the in vitro RANKLmediated osteoclastogenesis, respectively, in different dose patterns, 2012, pp.18, 621~630
29. Goldman L, "Current laser dentistry", Lasers Surg Med, 6, pp.559~562 (1987)
30. Stein A, "Low-level laser irradiation promotes proliferation and differentiation of human osteoblasts in vitro", Photomed Laser Surg, 23, pp.161~166 (2005)
31. Renno AC, "The effects of laser irradiation on osteoblast and osteosarcoma cell proliferation and differentiation in vitro", Photomed Laser Surg, 25, pp.275~280 (2007)
32. Kiyosaki T, "Low-level laser therapy stimulates mineralization via increased Runx2 expression and ERK phosphorylation in osteoblasts", Photomed Laser Surg, 28(Suppl 1), pp.S167~S172 (2010)
33. 신상훈, "Effect of low-level laser therapy on bisphosphonate-treated osteoblasts", Maxillofacial Plastic Reconstructive Surgery, 38(11), pp.1~8 (2016), 대한악안면성형재건외과학회[DOI]
34. Hirata S, "Low-level laser irradiation enhances BMP-induced osteoblast differentiation by stimulating the BMP", Smad signaling pathway, 2010, pp.111, 1445~1452

관련 논문AI추천